# Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement

> **NCT00107900** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 606 (actual)

## Conditions studied

- Arthroplasty, Replacement, Hip
- Thrombosis

## Interventions

- **DRUG:** DU-176b

## Key facts

- **NCT ID:** NCT00107900
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 606 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107900, "Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00107900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*